Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

Serruys, Patrick W; Silber, Sigmund; Garg, Scot; van Geuns, Robert Jan; Richardt, Gert; Buszman, Pawel E; Kelbaek, Henning; van Boven, Adrianus Johannes; Hofma, Sjoerd H; Linke, Axel; Klauss, Volker; Wijns, William; Macaya, Carlos; Garot, Philippe; DiMario, Carlo; Manoharan, Ganesh; Kornowski, Ran; Ischinger, Thomas; Bartorelli, Antonio; Ronden, Jacintha; ... (2010). Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. New England journal of medicine NEJM, 363(2), pp. 136-46. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa1004130

Full text not available from this repository. (Request a copy)

New-generation coronary stents that release zotarolimus or everolimus have been shown to reduce the risk of restenosis. However, it is unclear whether there are differences in efficacy and safety between the two types of stents on the basis of prospectively adjudicated end points endorsed by the Food and Drug Administration.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan




Massachusetts Medical Society MMS




Factscience Import

Date Deposited:

04 Oct 2013 14:10

Last Modified:

16 Jul 2018 14:56

Publisher DOI:


PubMed ID:


Web of Science ID:


URI: (FactScience: 203412)

Actions (login required)

Edit item Edit item
Provide Feedback